Despite these limitations, this study suggests that TAND is a novel 3R/4R tauopathy independent of amyloid plaque formation, and points to promising new directions for research into the mechanism of TAND symptoms and novel anti-tau therapies in AD. The gene discussed is MAPT; the disease is tauopathy.